======= MLLT10 ======= == Gene Information == * **Official Symbol**: MLLT10 * **Official Name**: MLLT10 histone lysine methyltransferase DOT1L cofactor * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8028|8028]] * **UniProt**: [[https://www.uniprot.org/uniprot/P55197|P55197]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MLLT10&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MLLT10|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602409|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a transcription factor and has been identified as a partner gene involved in several chromosomal rearrangements resulting in various leukemias. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2010]. * **UniProt Summary**: Probably involved in transcriptional regulation. In vitro or as fusion protein with KMT2A/MLL1 has transactivation activity. Binds to cruciform DNA. {ECO:0000269|PubMed:17868029}. |PHD| |nucleosome binding| |histone binding| |chromatin binding| |protein-containing complex| |DNA-binding transcription factor activity| |positive regulation of transcription by RNA polymerase II| |DNA binding| |positive regulation of transcription, DNA-templated| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of RNA metabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|-2.05| |[[:results:exp72|LB-100 4.1μM R02 exp72]]|-1.81| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|1.81| |[[:results:exp96|BI-2536 0.02μM R03 exp96]]|1.86| |[[:results:exp448|Ammonium tetrathiomolybdate 10μM R08 exp448]]|1.92| |[[:results:exp507|Monensin 0.3μM R08 exp507]]|2.16| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|2.41| ^Gene^Correlation^ |[[:human genes:d:dot1l|DOT1L]]|0.521| |[[:human genes:m:med13l|MED13L]]|0.416| Global Fraction of Cell Lines Where Essential: 1/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|1/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10494 * **Expression level (log2 read counts)**: 6.05 {{:chemogenomics:nalm6 dist.png?nolink |}}